Protein signatures to distinguish aggressive from indolent prostate cancer.

Fernando Jose Garcia Marques Shiqin LiuSarah M TottenAbel BermudezCheylene R Tanimoto En-Chi HsuRosalie NolleyAmy HembreeTanya StoyanovaJames D BrooksSharon J Pitteri

Published in: The Prostate (2022)

The protein signatures identified could improve understanding of the molecular drivers of aggressive prostate cancer and be used as candidate prognostic biomarkers.

Keyphrases

prostate cancer
radical prostatectomy
protein protein
amino acid
binding protein
small molecule
hodgkin lymphoma